The store will not work correctly when cookies are disabled.
3,5-dichloro-N-[3-chloro-4-(3,5-dihydroxyphenoxy)phenyl]-2-hydroxy-benzamide
ID: ALA4751500
PubChem CID: 162652130
Max Phase: Preclinical
Molecular Formula: C19H12Cl3NO5
Molecular Weight: 440.67
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccc(Oc2cc(O)cc(O)c2)c(Cl)c1)c1cc(Cl)cc(Cl)c1O
Standard InChI: InChI=1S/C19H12Cl3NO5/c20-9-3-14(18(26)16(22)4-9)19(27)23-10-1-2-17(15(21)5-10)28-13-7-11(24)6-12(25)8-13/h1-8,24-26H,(H,23,27)
Standard InChI Key: PZIMSFYWCFYPLQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
15.0528 -27.5291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0536 -28.3522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7662 -28.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4745 -28.3485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4698 -27.5222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7606 -27.1189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1879 -28.7585 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.8981 -28.3430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6088 -28.7574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3185 -28.3426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3158 -27.5204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5974 -27.1147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8905 -27.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6091 -29.5787 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
20.0255 -27.1081 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7394 -27.5130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4491 -27.1007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7437 -28.3343 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1574 -27.5078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8666 -27.0962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8628 -26.2740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1438 -25.8652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4417 -26.2833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7261 -25.8770 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1367 -25.0439 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
23.5804 -27.5015 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.3461 -28.7613 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.7574 -26.3017 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
9 14 1 0
11 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
23 24 1 0
22 25 1 0
20 26 1 0
2 27 1 0
6 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 440.67 | Molecular Weight (Monoisotopic): 438.9781 | AlogP: 5.81 | #Rotatable Bonds: 4 |
Polar Surface Area: 99.02 | Molecular Species: ACID | HBA: 5 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 5.95 | CX Basic pKa: ┄ | CX LogP: 5.47 | CX LogD: 4.09 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.41 | Np Likeness Score: -0.73 |
References
1. Fujii S,Kikuchi E,Watanabe Y,Suzuyama H,Ishigami-Yuasa M,Mori T,Isobe K,Uchida S,Kagechika H. (2020) Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling., 30 (17): [PMID:32738993] [10.1016/j.bmcl.2020.127408] |